Name: Pharmaceutical Metrics: Measuring and Improving R & D Performance (en Inglés)
SKU: 56082973
Price: 1663.32 MXN
Availability: InStock
Author: Zuckerman, David S.
ISBN: 9781138254763

portada Pharmaceutical Metrics: Measuring and Improving R & D Performance (en Inglés)

Pharmaceutical Metrics: Measuring and Improving R & D Performance (en Inglés)

Formato

Libro Físico

Autor

David S. Zuckerman

Editorial

Routledge

Idioma

Inglés

N° páginas

148

Encuadernación

Tapa Blanda

ISBN13

9781138254763

N° edición

Categorías

Empresa y gestión
Teoría general del derecho
Farmacia/prescripción/dispensación

Pharmaceutical Metrics: Measuring and Improving R & D Performance (en Inglés)

David S. Zuckerman (Autor) · Routledge · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 2,772.20$ 1,663.32

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 1,663.32

¡Envío Gratis! Llega entre el 08 Oct y el 16 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Pharmaceutical Metrics: Measuring and Improving R & D Performance (en Inglés)"

'What gets measured gets fixed' and this is as true of the pharmaceutical industry as any other. The problem is that pharmaceutical businesses are complex. Drug research and development involves extended and expensive processes; defining appropriate metrics for these processes is not easy, yet ineffective or misguided metrics can be more damaging than none at all. David Zuckerman's Pharmaceutical Metrics is an extremely practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results. And because metrics are about how to shape and develop your business, he explores how to deploy them organization-wide and make sure that they are driving business improvement. In order to reflect the needs of different types of pharmaceutical company the author uses four sample companies, throughout the book, to illustrate the principles for 'big pharma', 'micro pharma', a virtual development company and a CRO. This highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R&D, supported by case studies of the techniques applied and tips for optimizing the system.